Albany, NY, Jan. 13, 2016 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research entitled “Patient Registry Software Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” the global patient registry software market is expected to reach a value of US$2,077.1 mn by 2023. The market is estimated to expand at a CAGR of 10.30% during the forecast period from 2015 to 2023. The need for population health and disease management, government initiatives for enhancing the efficiency and availability of medical services, need for efficiency and accuracy in patient database management, and the need for decreasing the cost of clinical trials are the key factors driving the growth of patient registry software market, globally.
North America was the largest geographical market for patient registry software in 2014 with a 45.0% share in the total market. Asia Pacific is expected to emerge as the fastest-growing market with an estimated CAGR of 11.60% during the forecast period (2015 – 2023). The growing number of chronic diseases such as diabetes and cardiovascular ailments in North America, coupled with the need for reduction in costs and speeding up of large clinical trials are mainly driving the growth of patient registry software in North America.
Browse Market Research Report on Patient Registry Software Market: http://www.transparencymarketresearch.com/patient-registry-software-market.html
The commercial patient registry segment occupied approximately 83% share of the patient registry software market by type in 2014. The commercial patient registry software enables simultaneous entry and viewing of data by a large number of users as it has a more scalable, flexible structure, and optimized database for vast amounts of data. The public domain registry software segment is growing the fastest, with an expected CAGR of 11.80% during the forecast period due to their easy availability on public websites and their simple structure.
Diabetes registry software was the largest segment of the home security hardware market, accounting for more than one third of the total patient registry software market in 2014. The continuously rising prevalence of diabetes worldwide has aided the continuous growth of diabetes registry software market.
Browse Press Release of Patient Registry Software Market:http://www.transparencymarketresearch.com/pressrelease/patient-registry-software-market.htm
The government end-user segment is the largest in the patient registry software market, accounting for nearly two thirds of the total patient registry software market in the year 2014. The commercial end-user segment is the fastest-growing segment, projected to grow at a CAGR of 10.70% from 2015 to 2023. Rising government concerns over medical services and need for information services among various government agencies and legal authorities has led to the adoption of patient registry software among government end-users.
Leading patient registry software providers in 2014 include Global Vision Technologies, Inc., Quintiles Inc., Dacima Software Inc., PatientCrossroads, and EvadoeClinical Solutions.
Browse Article:http://www.transparencymarketresearch.com/article/patient-registry-software-market.htm
The global patient registry software market is segmented as below:
Patient Registry Software Market
By Type
- Public Domain Registry Software
- Commercial Registry Software
By Disease Areas
- Diabetes Registry
- Cardiovascular Registry
- Cancer Registry
- Rare Disease/Orphan Disease Registry
- Other Chronic Disease Registry
Other Reports by Transparency Market Research:
- Patient Engagement Solutions Market: http://www.transparencymarketresearch.com/patient-engagement-solutions-market.html
- Healthcare Mobility Solutions Market:http://www.transparencymarketresearch.com/healthcare-mobility-solutions-market.html
- Laboratory Information System Market:http://www.transparencymarketresearch.com/laboratory-information-systems.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anta Sports Expands Global Footprint With Strategic Puma Stake
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



